Guardant Health (NASDAQ:GH) Stock Rating Reaffirmed by Citigroup

Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “buy” rating reissued by Citigroup in a research note issued on Monday, Benzinga reports. They currently have a $50.00 target price on the stock. Citigroup’s price target would suggest a potential upside of 72.24% from the company’s current price. Several other equities research analysts have […]

Related Keywords

United States ,Piper Sandler ,William Blair ,Kumud Kalia ,Sanfordc Bernstein ,Guardant Health Inc ,News Ratings For Guardant Health Daily ,Securities Exchange Commission ,Temasek Holdings Private Ltd ,Institutional Investors Weigh In On Guardant Health ,Analyst Recommendations For Guardant Health ,Capital International Investors ,Citigroup ,Eventide Asset Management ,Guardant Health ,Morgan Stanley ,Guardant Health Stock Performance ,Nasdaq ,Get Free Report ,Exchange Commission ,Asset Management ,International Investors ,Holdings Private Ltd ,Deep Track Capital ,Next Test ,Guardant Health Daily ,Nasdaq Gh ,Ugh ,Medical ,Reiterated Rating ,Citigroup Inc ,